5 min listen
Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders
Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders
ratings:
Length:
5 minutes
Released:
Feb 12, 2024
Format:
Podcast episode
Description
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.
Released:
Feb 12, 2024
Format:
Podcast episode
Titles in the series (99)
March 19, 2020 Issue Introduction: Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the March 19, 2020 issue. by Neurology Today in 5